Application Information

Application Number : 2023/012480

Application Date : 01-12-2016

Application Type : EPC Fasikül

Grant Number : 2023-GE-652096

Grant Date : 04-10-2023

Registration Number : 2023 012480

Registration Date : 2023-10-23

Protection Type : Patent

European Patent Publication Number (B1) : EP3384049B1

European Patent Application Number : EP16823372.4

Applicants

Person No	Name	Address
7573749	REGENERON PHARMACEUTICALS, INC.	777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 A.B.D.

Inventors

Person No	Name	Address
7573746	Lorah PERLEE	C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 A.B.D.
7573748	Charles PAULDING	TARRYTOWN, NY 10591 A.B.D.
7573747	Sara HAMON	C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 A.B.D.

Invention Information

Name Of Invention	ANTI-VEGF İLE TEDAVİ EDİLEN YAŞA BAĞLI MAKULA DEJENERASYONU OLAN HASTALARDA GENETİK VARYANTLARI KLİNİK SONUÇ İLE İLİŞKİLENDİRME YÖNTEMLERİ
Summary Of Invention	Mevcut buluş, ıslak makula dejenerasyonu tedavisinin bir yönteminde kullanılmak üzere bir vasküler endotelyal büyüme faktörü (VEGF) inhibitörü ile ilgilidir.

Attorney Information

Name	ZEHRA KÖLÜK DESTEK PATENT A.Ş.
Address	Maslak mah. Saat sk. Spıne tower no:5 Sarıyer/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
03-12-2015	US 201562262589P	US
04-02-2016	US 201662291274P	US

Classes of The Invention

IPC
C12Q1/6883

Patent Application Procedures

Date	Date of Notification	Operation
24-11-2025		Yıllık Ücret Ödeme Talebi
25-11-2024		Yıllık Ücret Ödeme Talebi
23-11-2023		Yıllık Ücret Ödeme Talebi
	06-10-2023	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
04-10-2023		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
23-10-2023	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
8	2023	23-11-2023	3038.44
9	2024	25-11-2024	5190.0
10	2025	24-11-2025	8090.0